Horizon Two: HR NDMM (MMRC-100)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hearn Jay Cho, MD, PhD
Multiple Myeloma Research Foundation
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Emory University
Atlanta, Georgia, United States
Recruiting - Uchicago Medicine
Chicago, Illinois, United States
Recruiting - Karmanos Cancer Institute
Detroit, Michigan, United States
Recruiting - Mayo Clinic
Rochester, Minnesota, United States
Recruiting - Washington University Medical Center
St Louis, Missouri, United States
Recruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting - Unc
Chapel Hill, North Carolina, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2026
- Primary completion
- 1 Oct 2035
- Completion
- 12 Oct 2035
- Last update posted
- 10 Jun 2026
- Registered enrollment
- 300
- Registry id
- NCT07053436
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.